Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. S...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's research & therapy Vol. 12; no. 1; pp. 37 - 14
Main Authors Marquié, Marta, Valero, Sergi, Castilla-Marti, Miguel, Martínez, Joan, Rodríguez-Gómez, Octavio, Sanabria, Ángela, Tartari, Juan Pablo, Monté-Rubio, Gemma C., Sotolongo-Grau, Oscar, Alegret, Montserrat, Pérez-Cordón, Alba, Roberto, Natalia, de Rojas, Itziar, Moreno-Grau, Sonia, Montrreal, Laura, Hernández, Isabel, Rosende-Roca, Maitee, Mauleón, Ana, Vargas, Liliana, Abdelnour, Carla, Gil, Silvia, Esteban-De Antonio, Ester, Espinosa, Ana, Ortega, Gemma, Lomeña, Francisco, Pavia, Javier, Vivas, Assumpta, Tejero, Miguel Ángel, Gómez-Chiari, Marta, Simó, Rafael, Ciudin, Andreea, Hernández, Cristina, Orellana, Adelina, Benaque, Alba, Ruiz, Agustín, Tárraga, Lluís, Boada, Mercè
Format Journal Article
LanguageEnglish
Published London BioMed Central 31.03.2020
BMC
Subjects
Online AccessGet full text
ISSN1758-9193
1758-9193
DOI10.1186/s13195-020-00602-9

Cover

Abstract Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p  = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p  = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β  = 0.23, p  = 0.004; at v2: β  = 0.26, p  = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
AbstractList Abstract Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake.BACKGROUNDOptical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake.We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD.AIMSWe investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD.One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2.METHODSOne hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2.Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months.RESULTSMean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months.Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.CONCLUSIONSSubtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p  = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p  = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β  = 0.23, p  = 0.004; at v2: β  = 0.26, p  = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.
ArticleNumber 37
Author Pavia, Javier
Ortega, Gemma
Tejero, Miguel Ángel
Alegret, Montserrat
Rosende-Roca, Maitee
Gómez-Chiari, Marta
Ciudin, Andreea
Benaque, Alba
Sanabria, Ángela
Boada, Mercè
Roberto, Natalia
Simó, Rafael
Ruiz, Agustín
Martínez, Joan
Hernández, Isabel
Orellana, Adelina
Mauleón, Ana
Vargas, Liliana
Valero, Sergi
Marquié, Marta
Monté-Rubio, Gemma C.
Montrreal, Laura
Castilla-Marti, Miguel
Hernández, Cristina
Tárraga, Lluís
Vivas, Assumpta
Tartari, Juan Pablo
Sotolongo-Grau, Oscar
Esteban-De Antonio, Ester
Rodríguez-Gómez, Octavio
Espinosa, Ana
Abdelnour, Carla
de Rojas, Itziar
Lomeña, Francisco
Moreno-Grau, Sonia
Gil, Silvia
Pérez-Cordón, Alba
Author_xml – sequence: 1
  givenname: Marta
  surname: Marquié
  fullname: Marquié, Marta
  email: mmarquie@fundacioace.org
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 2
  givenname: Sergi
  surname: Valero
  fullname: Valero, Sergi
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 3
  givenname: Miguel
  surname: Castilla-Marti
  fullname: Castilla-Marti, Miguel
  organization: Clínica Oftalmológica Dr. Castilla, Department of Ophthalmology, Hospital del Mar and Hospital de l’Esperança - Parc de Salut Mar
– sequence: 4
  givenname: Joan
  surname: Martínez
  fullname: Martínez, Joan
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 5
  givenname: Octavio
  surname: Rodríguez-Gómez
  fullname: Rodríguez-Gómez, Octavio
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 6
  givenname: Ángela
  surname: Sanabria
  fullname: Sanabria, Ángela
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 7
  givenname: Juan Pablo
  surname: Tartari
  fullname: Tartari, Juan Pablo
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 8
  givenname: Gemma C.
  surname: Monté-Rubio
  fullname: Monté-Rubio, Gemma C.
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 9
  givenname: Oscar
  surname: Sotolongo-Grau
  fullname: Sotolongo-Grau, Oscar
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 10
  givenname: Montserrat
  surname: Alegret
  fullname: Alegret, Montserrat
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 11
  givenname: Alba
  surname: Pérez-Cordón
  fullname: Pérez-Cordón, Alba
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 12
  givenname: Natalia
  surname: Roberto
  fullname: Roberto, Natalia
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 13
  givenname: Itziar
  surname: de Rojas
  fullname: de Rojas, Itziar
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 14
  givenname: Sonia
  surname: Moreno-Grau
  fullname: Moreno-Grau, Sonia
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 15
  givenname: Laura
  surname: Montrreal
  fullname: Montrreal, Laura
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 16
  givenname: Isabel
  surname: Hernández
  fullname: Hernández, Isabel
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 17
  givenname: Maitee
  surname: Rosende-Roca
  fullname: Rosende-Roca, Maitee
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 18
  givenname: Ana
  surname: Mauleón
  fullname: Mauleón, Ana
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 19
  givenname: Liliana
  surname: Vargas
  fullname: Vargas, Liliana
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 20
  givenname: Carla
  surname: Abdelnour
  fullname: Abdelnour, Carla
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 21
  givenname: Silvia
  surname: Gil
  fullname: Gil, Silvia
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 22
  givenname: Ester
  surname: Esteban-De Antonio
  fullname: Esteban-De Antonio, Ester
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 23
  givenname: Ana
  surname: Espinosa
  fullname: Espinosa, Ana
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 24
  givenname: Gemma
  surname: Ortega
  fullname: Ortega, Gemma
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 25
  givenname: Francisco
  surname: Lomeña
  fullname: Lomeña, Francisco
  organization: Department of Radiology, Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona
– sequence: 26
  givenname: Javier
  surname: Pavia
  fullname: Pavia, Javier
  organization: Department of Radiology, Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona
– sequence: 27
  givenname: Assumpta
  surname: Vivas
  fullname: Vivas, Assumpta
  organization: Department of Diagnostic Imaging, Clínica Corachan
– sequence: 28
  givenname: Miguel Ángel
  surname: Tejero
  fullname: Tejero, Miguel Ángel
  organization: Department of Diagnostic Imaging, Clínica Corachan
– sequence: 29
  givenname: Marta
  surname: Gómez-Chiari
  fullname: Gómez-Chiari, Marta
  organization: Department of Diagnostic Imaging, Clínica Corachan
– sequence: 30
  givenname: Rafael
  surname: Simó
  fullname: Simó, Rafael
  organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB)
– sequence: 31
  givenname: Andreea
  surname: Ciudin
  fullname: Ciudin, Andreea
  organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB)
– sequence: 32
  givenname: Cristina
  surname: Hernández
  fullname: Hernández, Cristina
  organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB)
– sequence: 33
  givenname: Adelina
  surname: Orellana
  fullname: Orellana, Adelina
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 34
  givenname: Alba
  surname: Benaque
  fullname: Benaque, Alba
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC)
– sequence: 35
  givenname: Agustín
  surname: Ruiz
  fullname: Ruiz, Agustín
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 36
  givenname: Lluís
  surname: Tárraga
  fullname: Tárraga, Lluís
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
– sequence: 37
  givenname: Mercè
  surname: Boada
  fullname: Boada, Mercè
  organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32234080$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAiyQJTZsAr7lYhZIQ9XSkSqx6d5y7JMZDxm72M5U8zY8AzwCe54JZ6aUtotKkXLkfP_vc07-4-LAeQdF8Zrg94S09YdIGBFViSkuMa4xLcWz4og0VVsKItjBvfqwOI5xlaGatvxFccgoZRy3-Kj4MYvRa6uS9Q51kG4AHAqQrFMDSkurvzmIESln0J-fpVpvB28N6oKyDimtx_U47LV2eozdWDOqIaIbm5Yojt0KdLIbQNovnN1VBvRgHXxE56MzStvfv9Ds9AxdgBrScos-76znE6wm_mXxvM-G8Or2fVJcnZ9dnV6Ul1-_zE9nl6WuOE55Sk4I7lXVNryvuaLC1H2lOwxQa821AdEK0jei64ShQrBO5AVwWgHLaxHspJjvbY1XK3kd7FqFrfTKyt2BDwupQrJ6ANlogxvSMdbinhvaKtPXjHdVp3poqx6y16e91_XYrcFocCmo4YHpwy_OLuXCb2STR2gYzgbvbg2C_z5CTHJto4ZhUA78GCVlbdVQXokmo28foSs_hvzzJiovpSGCk0y9ud_RXSv_cpABugd08DEG6O8QguUUNrkPm8xhk7uwyWln7SORtmmXhjyVHZ6Wsr005nvcAsL_tp9Q_QUede1q
CitedBy_id crossref_primary_10_3390_ijms23052486
crossref_primary_10_1136_bmjopen_2023_072626
crossref_primary_10_3389_fneur_2022_1014359
crossref_primary_10_1016_j_snb_2024_135364
crossref_primary_10_14283_jpad_2023_118
crossref_primary_10_1136_bmjopen_2021_054657
crossref_primary_10_1111_jcmm_18495
crossref_primary_10_1111_cns_14525
crossref_primary_10_1002_dad2_12275
crossref_primary_10_3389_fnins_2023_1076177
crossref_primary_10_1038_s41598_022_21558_w
crossref_primary_10_4103_1673_5374_371380
crossref_primary_10_3390_biomedicines11072024
crossref_primary_10_2147_EB_S235238
crossref_primary_10_1186_s13195_024_01616_3
crossref_primary_10_1016_j_preteyeres_2020_100938
crossref_primary_10_1167_tvst_13_2_16
crossref_primary_10_3233_JAD_220596
crossref_primary_10_1007_s11011_022_00927_4
crossref_primary_10_1016_j_preteyeres_2024_101273
crossref_primary_10_1177_11206721211016311
crossref_primary_10_1186_s13195_025_01676_z
crossref_primary_10_3233_JAD_200735
crossref_primary_10_1097_WNO_0000000000001673
crossref_primary_10_1002_acn3_52172
crossref_primary_10_1002_dad2_12421
crossref_primary_10_1186_s13195_024_01408_9
Cites_doi 10.1038/s41598-018-34577-3
10.1111/aos.14121
10.1097/IJG.0b013e318133fb32
10.1212/WNL.0b013e318245d295
10.1016/j.jalz.2016.03.001
10.1371/journal.pone.0116802
10.3389/fnagi.2017.00214
10.1016/S0002-9394(03)00792-X
10.1016/j.jalz.2014.01.001
10.1007/s13311-016-0481-z
10.3233/JAD-160915
10.1002/wsbm.22
10.1016/j.dadm.2016.09.001
10.1016/S0161-6420(90)32621-0
10.1016/j.jalz.2018.10.003
10.1016/j.archger.2014.10.015
10.1001/jama.2015.4668
10.1001/jamaophthalmol.2018.3556
10.1212/WNL.0000000000000856
10.1371/journal.pone.0076436
10.1111/aos.12614
10.1038/mp.2017.146
10.1364/OE.18.021293
10.1016/0022-3956(75)90026-6
10.1080/13803395.2012.666230
10.1016/j.jalz.2011.10.007
10.1016/j.jalz.2013.03.006
10.1016/S1474-4422(14)70194-2
10.1016/j.jalz.2011.03.005
10.1097/IAE.0b013e3181dde71e
10.1001/jama.2015.4669
10.3233/JAD-150594
10.1016/S0028-3932(01)00055-0
10.1016/j.jalz.2009.10.002
10.1007/s00415-014-7374-z
10.1016/j.neuroimage.2010.06.020
10.1126/scitranslmed.3002609
10.1212/WNL.43.11.2412-a
10.1080/13803395.2011.630652
10.1038/s41598-019-45055-9
10.1038/eye.2015.94
10.1186/s13195-017-0239-9
10.1016/j.visres.2017.05.009
ContentType Journal Article
Contributor Ibarria, M
Nogales, A B
Sarasa, M
Martín, E
Berthier, M
Romero, J
Lafuente, A
Torres, M
Guitart, M
Preckler, S
Pancho, A
Campos, F
Bullich, S
Núñez, L
Pesini, P
Giménez, J
Buendia, M
Gailhajanet, A
Páez, A
Ruiz, S
Pérez-Grijalba, V
Aguilera, N
Cuevas, C
Cañabate, P
Gismondi, R
Moreno, M
Pelejà, E
Contributor_xml – sequence: 1
  givenname: N
  surname: Aguilera
  fullname: Aguilera, N
– sequence: 2
  givenname: M
  surname: Berthier
  fullname: Berthier, M
– sequence: 3
  givenname: M
  surname: Buendia
  fullname: Buendia, M
– sequence: 4
  givenname: S
  surname: Bullich
  fullname: Bullich, S
– sequence: 5
  givenname: F
  surname: Campos
  fullname: Campos, F
– sequence: 6
  givenname: P
  surname: Cañabate
  fullname: Cañabate, P
– sequence: 7
  givenname: C
  surname: Cuevas
  fullname: Cuevas, C
– sequence: 8
  givenname: A
  surname: Gailhajanet
  fullname: Gailhajanet, A
– sequence: 9
  givenname: J
  surname: Giménez
  fullname: Giménez, J
– sequence: 10
  givenname: R
  surname: Gismondi
  fullname: Gismondi, R
– sequence: 11
  givenname: M
  surname: Guitart
  fullname: Guitart, M
– sequence: 12
  givenname: M
  surname: Ibarria
  fullname: Ibarria, M
– sequence: 13
  givenname: A
  surname: Lafuente
  fullname: Lafuente, A
– sequence: 14
  givenname: E
  surname: Martín
  fullname: Martín, E
– sequence: 15
  givenname: M
  surname: Moreno
  fullname: Moreno, M
– sequence: 16
  givenname: A B
  surname: Nogales
  fullname: Nogales, A B
– sequence: 17
  givenname: L
  surname: Núñez
  fullname: Núñez, L
– sequence: 18
  givenname: A
  surname: Páez
  fullname: Páez, A
– sequence: 19
  givenname: A
  surname: Pancho
  fullname: Pancho, A
– sequence: 20
  givenname: E
  surname: Pelejà
  fullname: Pelejà, E
– sequence: 21
  givenname: V
  surname: Pérez-Grijalba
  fullname: Pérez-Grijalba, V
– sequence: 22
  givenname: P
  surname: Pesini
  fullname: Pesini, P
– sequence: 23
  givenname: S
  surname: Preckler
  fullname: Preckler, S
– sequence: 24
  givenname: J
  surname: Romero
  fullname: Romero, J
– sequence: 25
  givenname: S
  surname: Ruiz
  fullname: Ruiz, S
– sequence: 26
  givenname: M
  surname: Sarasa
  fullname: Sarasa, M
– sequence: 27
  givenname: M
  surname: Torres
  fullname: Torres, M
Copyright The Author(s) 2020
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor on behalf of the FACEHBI study group
FACEHBI study group
CorporateAuthor_xml – name: on behalf of the FACEHBI study group
– name: FACEHBI study group
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13195-020-00602-9
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1758-9193
EndPage 14
ExternalDocumentID oai_doaj_org_article_7cd071b3380f4d28adf634b5bafe85fe
PMC7110730
32234080
10_1186_s13195_020_00602_9
Genre Journal Article
GrantInformation_xml – fundername: Araclon Biotech
  grantid: N/A
– fundername: Laboratorio de análisis Echevarne
  grantid: N/A
– fundername: Alkahest
  grantid: N/A
– fundername: Grifols
– fundername: Fundació ACE Institut Català de Neurociències Aplicades
  grantid: N/A
– fundername: European Foundation for the Study of Diabetes - ESFS/Lilly Mental Health and Diabetes 2013 Programme
– fundername: IrsiCaixa
  grantid: N/A
– fundername: Life Molecular Imaging
  grantid: N/A
– fundername: H2020 Marie Skłodowska-Curie Actions
  grantid: 796706
  funderid: http://dx.doi.org/10.13039/100010665
– fundername: H2020 Marie Skłodowska-Curie Actions
  grantid: 796706
– fundername: ;
– fundername: ;
  grantid: N/A
– fundername: ;
  grantid: 796706
GroupedDBID ---
0R~
23M
2WC
53G
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFS
ACIHN
ACJQM
ACUHS
ADBBV
ADUKV
AEAQA
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
O9-
OK1
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
AAYXX
ALIPV
CITATION
-56
-5G
-BR
3V.
ACRMQ
ADINQ
C24
NPM
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c540t-914110fa5874f64a29d6f5cb0ee6cc4cde9891f79bb9d2993b9408425e300693
IEDL.DBID 7X7
ISSN 1758-9193
IngestDate Wed Aug 27 01:31:55 EDT 2025
Thu Aug 21 14:05:52 EDT 2025
Fri Sep 05 05:39:50 EDT 2025
Sun Sep 07 03:30:14 EDT 2025
Thu Jan 02 22:59:18 EST 2025
Thu Apr 24 22:59:04 EDT 2025
Tue Jul 01 02:38:49 EDT 2025
Sat Sep 06 07:34:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords β-Amyloid
Florbetaben
Subjective cognitive decline
Optical coherence tomography
Retinal thickness
Positron emission tomography
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-914110fa5874f64a29d6f5cb0ee6cc4cde9891f79bb9d2993b9408425e300693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2391471941?pq-origsite=%requestingapplication%
PMID 32234080
PQID 2391471941
PQPubID 2040174
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_7cd071b3380f4d28adf634b5bafe85fe
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7110730
proquest_miscellaneous_2385724597
proquest_journals_2391471941
pubmed_primary_32234080
crossref_primary_10_1186_s13195_020_00602_9
crossref_citationtrail_10_1186_s13195_020_00602_9
springer_journals_10_1186_s13195_020_00602_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-31
PublicationDateYYYYMMDD 2020-03-31
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-31
  day: 31
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Alzheimer's research & therapy
PublicationTitleAbbrev Alz Res Therapy
PublicationTitleAlternate Alzheimers Res Ther
PublicationYear 2020
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References 602_CR44
J den Haan (602_CR13) 2017; 6
602_CR40
602_CR48
602_CR47
602_CR46
CR Jack (602_CR38) 2014; 13
S Ogata (602_CR6) 2015; 60
M Marquié (602_CR42) 2019; 9
K Goozee (602_CR35) 2018; 23
KM Rodrigue (602_CR39) 2012; 78
602_CR10
602_CR51
B Reisberg (602_CR5) 2010; 6
M Koronyo-Hamaoui (602_CR18) 2011; 54
F Jessen (602_CR4) 2014; 10
C Lamirel (602_CR16) 2009; 6
M Alegret (602_CR25) 2015; 48
GM McKhann (602_CR1) 2011; 7
RJ Kryscio (602_CR7) 2014; 83
CY Santos (602_CR49) 2018; 10
M Díaz-Coránguez (602_CR14) 2017; 139
WJ Jansen (602_CR37) 2015; 313
Alzheimer’s Association (602_CR2) 2016; 12
G Martínez (602_CR9) 2017; 11
602_CR22
AI Ramirez (602_CR50) 2017; 9
R Blesa (602_CR28) 2001; 39
S Hagen (602_CR41) 2011; 31
AA Sadun (602_CR17) 1990; 97
602_CR29
A Tas (602_CR19) 2015; 93
602_CR24
GJ Jaffe (602_CR12) 2004; 137
JC Morris (602_CR30) 1993; 43
Q Yang (602_CR34) 2010; 18
MS Byerly (602_CR15) 2009; 1
P Lozoya-Delgado (602_CR27) 2012; 54
M Boada (602_CR21) 2014; 10
M Alegret (602_CR23) 2012; 34
602_CR32
602_CR31
N Pakrou (602_CR33) 2008; 17
BT Hyman (602_CR8) 2012; 8
RA Sperling (602_CR3) 2011; 3
D Sánchez (602_CR43) 2018; 8
O Rodriguez-Gomez (602_CR20) 2017; 4
R Ossenkoppele (602_CR36) 2015; 313
BE O’Bryhim (602_CR45) 2018; 136
RE Amariglio (602_CR26) 2012; 34
SE Counts (602_CR11) 2017; 14
References_xml – volume: 8
  start-page: 16345
  issue: 1
  year: 2018
  ident: 602_CR43
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-34577-3
– ident: 602_CR46
  doi: 10.1111/aos.14121
– volume: 17
  start-page: 43
  issue: 1
  year: 2008
  ident: 602_CR33
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0b013e318133fb32
– volume: 78
  start-page: 387
  issue: 6
  year: 2012
  ident: 602_CR39
  publication-title: Neurology.
  doi: 10.1212/WNL.0b013e318245d295
– volume: 12
  start-page: 459
  issue: 4
  year: 2016
  ident: 602_CR2
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2016.03.001
– ident: 602_CR10
  doi: 10.1371/journal.pone.0116802
– volume: 9
  start-page: 214
  year: 2017
  ident: 602_CR50
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2017.00214
– volume: 137
  start-page: 156
  issue: 1
  year: 2004
  ident: 602_CR12
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(03)00792-X
– ident: 602_CR51
– volume: 10
  start-page: 844
  issue: 6
  year: 2014
  ident: 602_CR4
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2014.01.001
– volume: 11
  start-page: CD012883
  year: 2017
  ident: 602_CR9
  publication-title: Cochrane Database Syst Rev
– volume: 14
  start-page: 35
  issue: 1
  year: 2017
  ident: 602_CR11
  publication-title: Neurotherapeutics.
  doi: 10.1007/s13311-016-0481-z
– ident: 602_CR22
  doi: 10.3233/JAD-160915
– volume: 1
  start-page: 380
  issue: 3
  year: 2009
  ident: 602_CR15
  publication-title: Wiley Interdiscip Rev Syst Biol Med
  doi: 10.1002/wsbm.22
– ident: 602_CR47
  doi: 10.1016/j.dadm.2016.09.001
– volume: 97
  start-page: 9
  issue: 1
  year: 1990
  ident: 602_CR17
  publication-title: Ophthalmology.
  doi: 10.1016/S0161-6420(90)32621-0
– ident: 602_CR40
  doi: 10.1016/j.jalz.2018.10.003
– volume: 60
  start-page: 201
  issue: 1
  year: 2015
  ident: 602_CR6
  publication-title: Arch Gerontol Geriatr
  doi: 10.1016/j.archger.2014.10.015
– volume: 313
  start-page: 1924
  issue: 19
  year: 2015
  ident: 602_CR37
  publication-title: JAMA.
  doi: 10.1001/jama.2015.4668
– volume: 136
  start-page: 1242
  issue: 11
  year: 2018
  ident: 602_CR45
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2018.3556
– volume: 83
  start-page: 1359
  issue: 15
  year: 2014
  ident: 602_CR7
  publication-title: Neurology.
  doi: 10.1212/WNL.0000000000000856
– ident: 602_CR24
  doi: 10.1371/journal.pone.0076436
– volume: 93
  start-page: e507
  issue: 6
  year: 2015
  ident: 602_CR19
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.12614
– volume: 23
  start-page: 1807
  issue: 8
  year: 2018
  ident: 602_CR35
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2017.146
– ident: 602_CR31
– volume: 18
  start-page: 21293
  issue: 20
  year: 2010
  ident: 602_CR34
  publication-title: Opt Express
  doi: 10.1364/OE.18.021293
– ident: 602_CR29
  doi: 10.1016/0022-3956(75)90026-6
– volume: 34
  start-page: 580
  issue: 6
  year: 2012
  ident: 602_CR26
  publication-title: J Clin Exp Neuropsychol
  doi: 10.1080/13803395.2012.666230
– volume: 8
  start-page: 1
  issue: 1
  year: 2012
  ident: 602_CR8
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2011.10.007
– volume: 10
  start-page: 409
  issue: 3
  year: 2014
  ident: 602_CR21
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2013.03.006
– volume: 4
  start-page: 100
  issue: 2
  year: 2017
  ident: 602_CR20
  publication-title: J Prev Alzheimer’s Dis
– volume: 13
  start-page: 997
  issue: 10
  year: 2014
  ident: 602_CR38
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(14)70194-2
– volume: 7
  start-page: 263
  issue: 3
  year: 2011
  ident: 602_CR1
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2011.03.005
– volume: 31
  start-page: 41
  issue: 1
  year: 2011
  ident: 602_CR41
  publication-title: Retina.
  doi: 10.1097/IAE.0b013e3181dde71e
– volume: 313
  start-page: 1939
  issue: 19
  year: 2015
  ident: 602_CR36
  publication-title: JAMA.
  doi: 10.1001/jama.2015.4669
– volume: 48
  start-page: 1109
  issue: 4
  year: 2015
  ident: 602_CR25
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-150594
– volume: 6
  start-page: 162
  year: 2017
  ident: 602_CR13
  publication-title: Alzheimer’s Dement Diagn Assess Dis Monit.
– volume: 39
  start-page: 1150
  issue: 11
  year: 2001
  ident: 602_CR28
  publication-title: Neuropsychologia.
  doi: 10.1016/S0028-3932(01)00055-0
– volume: 6
  start-page: 11
  issue: 1
  year: 2010
  ident: 602_CR5
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2009.10.002
– ident: 602_CR48
  doi: 10.1007/s00415-014-7374-z
– volume: 54
  start-page: 137
  issue: 3
  year: 2012
  ident: 602_CR27
  publication-title: Rev Neurol
– volume: 54
  start-page: S204
  issue: Suppl 1
  year: 2011
  ident: 602_CR18
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2010.06.020
– volume: 3
  start-page: 111cm33
  issue: 111
  year: 2011
  ident: 602_CR3
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3002609
– volume: 10
  start-page: 196
  year: 2018
  ident: 602_CR49
  publication-title: Alzheimers Dement
– volume: 43
  start-page: 2412
  issue: 11
  year: 1993
  ident: 602_CR30
  publication-title: Neurology.
  doi: 10.1212/WNL.43.11.2412-a
– volume: 34
  start-page: 209
  issue: 2
  year: 2012
  ident: 602_CR23
  publication-title: J Clin Exp Neuropsychol
  doi: 10.1080/13803395.2011.630652
– volume: 9
  start-page: 8698
  issue: 1
  year: 2019
  ident: 602_CR42
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-45055-9
– ident: 602_CR32
  doi: 10.1038/eye.2015.94
– ident: 602_CR44
  doi: 10.1186/s13195-017-0239-9
– volume: 139
  start-page: 123
  year: 2017
  ident: 602_CR14
  publication-title: Vis Res
  doi: 10.1016/j.visres.2017.05.009
– volume: 6
  start-page: E105
  issue: 4
  year: 2009
  ident: 602_CR16
  publication-title: Rev Neurol Dis
SSID ssj0066284
Score 2.3697033
Snippet Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements....
Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple...
Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements....
Abstract Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 37
SubjectTerms Alzheimer's disease
Biomarkers
Biomedical and Life Sciences
Biomedicine
Brain research
Clinical trials
Cognitive ability
Dementia
Diabetes
Diabetic retinopathy
Disease
Florbetaben
Geriatric Psychiatry
Geriatrics/Gerontology
Glaucoma
Memory
Neurology
Neurosciences
Optic nerve
Optical coherence tomography
Optics
Pathology
Positron emission tomography
Retina
Retinal thickness
Software
Subject Cognitive Decline
Subjective cognitive decline
β-Amyloid
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQiL9AQUbiBlGd2LFjbm3VVUGCU5F6s_wrFmhasbsH3oZngEfgzjMxYyehy-8FKadkbFkz4_FMPN8MIY-T7r0DP6N2QspaONfW1rYSdVnbmJJkDgHOL1_J49fixWl3eqnVF-aElfLAhXF7ygc4BR1EUiyJ0PY2JMmF65xNse9SROvLNJuCqWKDpQSrO0Fkerm3aniTkciIopZgA_TWMZSr9f_Oxfw1U_Kn69J8Ci2uk2uj-0j3y7JvkCtxuEk-XeIxHROvKKITkRTz2d-hPaN2CPTb59qeQYy-DNRhcwhqvd-cjS286BKfCaC1oviPlq427m0xinRONaIhIqIyPqMLBJL45dcvdP_wiBZM00d6kKd-jsS5rvgtcrI4Ojk8rsfOC7UHD24NFlCAW5Bs1yuRpLCtDjJ13rEYpffCh6h73SSlndMBDjTutGB4oRc5lj7mt8nOcD7Eu4QqHgXzVqXWcWE9sxCiwLTcpZi60KWKNJMcjB-rkmNzjPcmRye9NEV2BmRnsuyMrsiTecxFqcnxV-oDFO9MifW08wvQMjNqmfmXllVkd1IOM27ylWk58Ek1WjQVeTR_hu2Jdy52iOcbpOk71QoI2ypyp-jSvBKwpRzYxiqitrRsa6nbX4blm1wCXGHYzmHk00kffyzrz6y49z9YcZ9cbfNGQlzmLtlZf9jEB-CYrd3DvAe_A0aaOkw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagXLigIl6BgozEDSKS-BX31q66KkhwKlJvlp9igaaI3T303_Q3lJ_Avb-JGedBFwoSUk7J2LI8D8_E880Q8iLp1jvwM0rHpSy5c01pbSNRlrWNKcnKIcD53Xt5-IG_PRbHQ5kcxMJcvb-vW_l6WbM6Y4gR_yxBe_VNckuA4UVpnsnZaHWlBDs7gmKuHbdx8OT6_Nc5lX_mRv52QZrPnfk2uTM4jHSv5_BdciN298j5lV2lQ6oVRTwikmIG-2e0YNR2gV5elPYEovJFoA7bQVDr_fpkaNpFF_iMkKwlxb-ydLl2n3ozSKfkIhoiYijjLp0jdMQvfnyne7MD2qOYzuh-nvoNEudK4vfJ0fzgaHZYDr0WSg8-2wpsHgdHIFnRKp4kt40OMgnvqhil99yHqFtdJ6Wd0wGOMOY0r_AKLzIsdswekK3utIuPCFUs8spblRrHuPWVBV7BtMylmEQQqSD1yAfjhzrk2A7ji8nxSCtNzzsDvDOZd0YX5OU05mtfheOf1PvI3okSK2jnFyBYZlBIo3wA78pBhF4lHprWhiQZd8LZFFuRYkF2RuEwg1ovTcNgn1SteV2Q59NnUEi8ZbFdPF0jTStUwyFQK8jDXpamlYD1ZLBtVUHUhpRtLHXzS7f4mIt-KwzUGYx8Ncrjr2X9fSse_x_5E3K7ySqDmMsdsrX6to5PwelauWdZ234CF0EpWw
  priority: 102
  providerName: Springer Nature
Title Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
URI https://link.springer.com/article/10.1186/s13195-020-00602-9
https://www.ncbi.nlm.nih.gov/pubmed/32234080
https://www.proquest.com/docview/2391471941
https://www.proquest.com/docview/2385724597
https://pubmed.ncbi.nlm.nih.gov/PMC7110730
https://doaj.org/article/7cd071b3380f4d28adf634b5bafe85fe
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXBBIF6BsjISN4iaxI4Tc0Hd1a4KEhVCRdqb5Scs0Gzb3T303_Ab4Cdw5zcx4zzK8qiUyyaTyOt5eMaeb4aQp0HW1oCfkRouRMqNKVKtC4GyLLUPQWQGAc5vjsThe_56Xs67DbdVl1bZ28RoqN3S4h75fsFkDoZU8vzl6VmKXaPwdLVroXGd7ObgiWDrhmo-BFxCgO3tgTK12F_lLI94ZMRSC7AEcmsxijX7_-Vo_p0v-cehaVyLZrfIzc6JpAct12-Ta765Q77-NtO0S7-iiFFEUsxq_4xWjerG0Z_fUn0CkfrCUYMtIqi2dnPSNfKiC7x6mNaK4k4tXW3Mp9Y00iHhiDqPuEr_gs4QTmIXP77Tg8mUtsimCzqOn36FxLG6-F1yPJseTw7Trv9CasGPW4Md5OAcBF3WFQ-C60I6EUprMu-Ftdw6L2uZh0oaIx0sa8xInuGxnmdYAJndIzvNsvEPCK2Y55nVVSgM49pmGgIV-CwzwYfSlSEhec8HZbva5Ngi44uKMUotVMs7BbxTkXdKJuTZ8M5pW5njSuoxsnegxKra8cby_IPqlFRV1oHHZSBqzwJ3Ra1dEIyb0ujg6zL4hOz1wqE6VV-pS8FMyJPhMSgpnrzoxi83SFOXVcEheEvI_VaWhpGARWUwbVlCqi0p2xrq9pNm8TEWAq8weGfw5vNeHi-H9f-peHj1v3hEbhRRRRB3uUd21ucb_xgcr7UZRe0akd3x9OjtO_g1EZNR3MT4BfR5M_Y
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKeoALAvFaKGAkOMGqu2uvd41UoaYkSmgbIRSk3iw_IdBuStMI5d_wG-DMiTu_CY93NyU8equUU3bW8nrGn8f2fDMIPXa81Mr7GbGijMVUqSyWMmNgy1xa51iigOC8P2KDt_TVQX6whr63XBgIq2wxMQC1mWo4I9_MCE89kHKavjj-FEPVKLhdbUtoyKa0gtkKKcYaYseuXXz2W7jZ1vCl1_eTLOv3xjuDuKkyEGvvrZz62U79EuhkXhbUMSozbpjLtUqsZVpTbSwveeoKrhQ3HryJ4jSByytLIM0v8c1eQusUzk86aL3bG71-0y4FjHnwb5k6JducpSQNhGggczMPRXxlNQxFA_7l6f4dsPnHrW1YDPvX0NXGi8XbtdldR2u2uoG-_KZq3MR_YSBJgiiE1X8EWMWyMvjn11geLQ6nE4MV1KjAfmTnR00lMTyBX8sTm2E4KsazufpQYzNeRjxhY4HYaZ_jPvBZ9OTHN7y908M1tWqBu6HpIQiH9OY30fgiVHMLdappZe8gXBBLEy0LlylCpU6k3yn5Zoly1uUmdxFKWz0I3SRHhxodhyJskkomat0JrzsRdCd4hJ4u3zmuU4OcK90F9S4lIa13-GN68k40KCEKbbzLpwgpE0dNVkrjGKEqV9LZMnc2QhutcYgGa2bibGZE6NHysUcJuPqRlZ3OQabMi4z63WOEbte2tOyJh3Tihy2JULFiZStdXX1STd6HTOQFnB4Q_-az1h7PuvX_obh7_lc8RJcH4_09sTcc7d5DV7IwXYAEuoE6pydze997gafqQTPXMBIXPLt_ARfYcnQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgLAvEKFDASN4iaxI4dc2uXrloeFYci9Wb5CQs0W3V3D_wbfgP8BO78JmacB10oSEh72owjy_PwTDzfZ0IeR9U4C3lGbrkQObe2yo2pBNqyMiFGUVgEOL8-EHtv-Yuj-ugMij91uw9Hkh2mAVma2uXWiY-dizdia1GyMiGLERUtwKfVRXIJubqwqW8iJkMsFgKi7wCVOXfc2naUWPvPSzX_7Jj87dg07UbTa-Rqn0bS7U7v18mF0N4gX86sNe0bsCiiFFEU-9o_YlyjpvX0x9fcHEOtPvPU4iUR1Di3Ou6v8qIz_A1ArQXFb7V0sbIfuuBIx5Yj6gMiK8MzOkVAiZt9_0a3J7u0wzZ9pjvp1fsonPjFb5LD6e7hZC_vb2DIHWRyS4iEHNKDaOpG8ii4qZQXsXa2CEE4x50PqlFllMpa5WFjY1aBFiAMBIYUyOwW2WjnbbhDqGSBF87IWFnGjSsMlCrwWmZjiLWvY0bKQQ_a9ezkeEnGJ52qlEboTncadKeT7rTKyJNxzEnHzfFP6R1U7yiJvNrpj_npO927qZbOQ85loW4vIvdVY3wUjNvamhiaOoaMbA7GoXtnX-iKwTrJUvEyI4_Gx-CmePZi2jBfoUxTy4pD-ZaR250tjTOBmMpg2YqMyDUrW5vq-pN29j5RgUss3xmMfDrY469p_X0p7v6f-ENy-c3zqX61f_DyHrlSJe9BUOYm2ViersJ9yMqW9kFyvJ-LSDSa
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+retinal+thickness+and+%CE%B2-amyloid+brain+accumulation+in+individuals+with+subjective+cognitive+decline%3A+Fundaci%C3%B3+ACE+Healthy+Brain+Initiative&rft.jtitle=Alzheimer%27s+research+%26+therapy&rft.au=Marqui%C3%A9%2C+Marta&rft.au=Valero%2C+Sergi&rft.au=Castilla-Marti%2C+Miguel&rft.au=Mart%C3%ADnez%2C+Joan&rft.date=2020-03-31&rft.issn=1758-9193&rft.eissn=1758-9193&rft.volume=12&rft.issue=1&rft.spage=37&rft_id=info:doi/10.1186%2Fs13195-020-00602-9&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-9193&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-9193&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-9193&client=summon